Cara Therapeutics | CARA - Capitale Sociale E Riserve

Prezzo Delle Azioni
3.39
Cambio Giornaliero
0.17 5.28%
Mensile
-1.45%
Annuale
-80.60%
Q2 Previsione
3.32




Capitale Sociale E Riserve Cambiamento Data
Acadia Pharmaceuticals USD 917.27M 94.89M 2025-09
Alterity Therapeutics Limited AUD 36.21M 18.58M 2025-12
Assertio Holdings USD 105.8M 12.5M 2025-09
Cara Therapeutics USD 27.87M 5.06M 2025-09
Cassava Sciences USD 74.4M 7.16M 2025-12
Chugai Pharma JPY 1.89T 95.02B 2025-09
Cipla INR 329.19B 16.3B 2025-09
Clal Biotechnology ILS 121.41M 4.62M 2023-12
Compugen USD 102.73M 58.9M 2025-12
CSL USD 18.66B 2.75B 2025-12
Grifols EUR 6.21B 133.12M 2025-12
Halozyme Therapeutics USD 48.81M 455.1M 2025-12
J&J USD 81.54B 3.07B 2025-12
Neurocrine Biosciences USD 3.25B 249.5M 2025-12
Pacira USD 693.11M 34.1M 2025-12
Pfizer USD 92.8B 4.11B 2025-09
RedHill Biopharma USD -4.41M 271K 2025-06
Supernus Pharmaceuticals USD 1.06B 12.05M 2025-12
Vanda Pharmaceuticals USD 327.19M 138.81M 2025-12